Cardiovascular risk factors correlate with prostate size in men with bladder outlet obstruction

BJU International

Volumn 92, Issue 1, 2003, Pages 64-68

  Sandfeldt, L ^a,b   Hahn, R G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Box 6424   (Sweden)

Author keywords

Adrenergic antagonists; BPH; Cardiovascular disease; ECG; Heart rate; Personality; Risk factors; Ultrasonography; Urodynamics

Indexed keywords

ADULT; AGED; ARTICLE; ASSERTIVENESS; BLADDER NECK STENOSIS; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; GLUCOSE BLOOD LEVEL; HEART RATE VARIABILITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; ORGAN SIZE; PERSONALITY; PRIORITY JOURNAL; PROSTATE; STATISTICAL ANALYSIS; SYMPATHETIC TONE; TRANSRECTAL ULTRASONOGRAPHY; URODYNAMICS;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; HEART RATE; HUMANS; MALE; MIDDLE AGED; PERSONALITY; PROSTATIC HYPERPLASIA; RISK FACTORS; URINARY BLADDER NECK OBSTRUCTION;

EID: 0037488434     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04277.x     Document Type: Article

References (23)

1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474-9
2. Koshiba K, Egawa S, Ohori M, Uchida T, Yokoyama E, Shoji K. Does transurethral resection of the prostate pose a risk to life? 22-year outcome. J Urol 1995; 153: 1506-9
3. Hammarsten J, Hogstedt B. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press 1999; 8: 29-36
4. Hahn RG, Farahmand BY, Hallin A, Hammar N, Persson PG. Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy. Urology 2000; 55: 236-40
5. Heyns CF, Rittoo D, Sutherland GR, Davie IT, Scott NB, Chisholm GD. Intra-operative myocardial ischaemia detected by biplane transoesophageal echocardiography during transurethral prostatectomy. Br J Urol 1993; 71: 716-20
6. Schalling D, Asberg M, Edman G, Oreland L. Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity. Acta Psychiatr Scand 1987; 76: 172-82
7. Anonymous. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996; 17: 354-81
8. Abrams PH, Griffiths DJ. The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br J Urol 1979; 51: 129-34
9. Jensen-Urstad M, Jensen-Urstad K, Ericson M, Johansson J. Heart rate variability is related to leucocyte count in men and to blood lipoproteins in women in a healthy population of 35-year-old subjects. J Intern Med 1998; 243: 33-40
10. Kampe T, Edman G, Hannerz H. Ten-year follow-up study of personality traits in adults with intact and restored dentitions. J Oral Rehabil 1996; 23: 443-9
11. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 1998; 44: 151-62
12. Januzzi JL, Stern TA, Pasternak RC, DeSanctis RW. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med 2000; 160: 1913-21
13. Hayano J, Yamada A, Mukai S et al. Severity of coronary atherosclerosis correlates with the respiratory component of heart rate variability. Am Heart J 1991; 121: 1070-9
14. Van Hoogenhuyze D, Weinstein N, Martin GJ et al. Reproducibility and relation to mean heart rate of heart rate variability in normal subjects and in patients with congestive heart failure secondary to coronary artery disease. Am J Cardiol 1991; 68: 1668-76
15. Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987; 59: 256-62
16. Roos NP, Wennberg JE, Malenka DJ et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 1989; 320: 1120-4
17. Malenka DJ, Roos N, Fisher ES et al. Further study of the increased mortality following transurethral prostatectomy: a chart-based analysis. J Urol 1990; 144: 224-7
18. Sidney S, Quesenberry CP Jr, Sadler MC, Cattolica EV, Lydick EG, Guess HA. Reoperation and mortality after surgical treatment of benign prostatic hypertrophy in a large prepaid medical care program. Med Care 1992; 30: 117-25
19. Hargreave TB, Heynes CF, Kendrick SW, Whyte B, Clarke JA. Mortality after transurethral and open prostatectomy in Scotland. Br J Urol 1996; 77: 547-53
20. Concato J, Horwitz RI, Feinstein AR, Elmore JG, Schiff SF. Problems of comorbidity in mortality after prostatectomy. JAMA 1992; 267: 1077-82
21. Seagroatt V. Mortality after prostatectomy. selection and surgical approach. Lancet 1995; 346: 1521-4
22. Rhodes T, Girman CJ, Jacobsen SJ, Roberts RO, Guess HA, Lieber MM. Longitudinal prostate growth rates during 5 years in randomly selected community men 40-79 years old. J Urol 1999; 161: 1174-9
23. Jensen-Urstad K, Storck N, Bouvier F, Ericson M, Lindblad LE, Jensen-Urstad M. Heart rate variability in healthy subjects is related to age and gender. Acta Physiol Scand 1997; 160: 235-41